Sign In
Buy HALO
$82.54
-0.760 (-0.91%)
At Close: Jul 31, 2026
Halozyme Therapeutics: Enhanced Prospects, Expensive Valuations
05:26pm, Tuesday, 30'th Jun 2020
Halozyme Therapeutics is an expensive stock that’s been living on its long-term loans. But it has a very exciting future. Janssen Biotech, its partner, has rece
Charting market cross currents, S&P 500 maintains 200-day average
04:47pm, Tuesday, 30'th Jun 2020
Technically speaking, the major U.S. benchmarks are poised to conclude June against an increasingly uneven, but still generally bullish, bigger-picture...
Halozyme Therapeutics’ (HALO) “Buy” Rating Reaffirmed at Piper Sandler
04:00am, Tuesday, 30'th Jun 2020
Piper Sandler restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO) in a research report released on Monday, TipRanks reports. The firm currently has a $28.00 price target on the
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 29)
ADC Therapeutics SA (...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has approved Roche's Phesgo™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) injection,
Halozyme Therapeutics, Inc. : The resistance should give in | MarketScreener
02:26pm, Friday, 26'th Jun 2020Traders Buy High Volume of Call Options on Halozyme Therapeutics (NASDAQ:HALO)
01:30am, Wednesday, 24'th Jun 2020
Halozyme Therapeutics, Inc. (NASDAQ:HALO) was the recipient of some unusual options trading on Tuesday. Stock traders bought 3,334 call options on the company. This is an increase of approximately 280
Wells Fargo & Company MN Acquires 109,476 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
07:28am, Tuesday, 23'rd Jun 2020
Wells Fargo & Company MN increased its holdings in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 10.9% during the first quarter, according to the company in its most recent disclosure with th
Halozyme Therapeutics : To Receive $10 Million Milestone Payment From Janssen | MarketScreener
12:01pm, Monday, 22'nd Jun 2020Halozyme To Receive $10 Million Milestone Payment From Janssen
12:00pm, Monday, 22'nd Jun 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the company will receive a $10 million milestone payment from Janssen Biotech, Inc. (Janssen) triggered under the Collaboration and License A
Stocks To Watch: Nike, Apple, Ford And Stressed Banks
08:39am, Saturday, 20'th Jun 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Why Halozyme Therapeutics (HALO) Stock Might be a Great Pick
12:32pm, Friday, 19'th Jun 2020
Halozyme Therapeutics (HALO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Deutsche Bank AG Sells 164,970 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
08:16am, Thursday, 18'th Jun 2020
Deutsche Bank AG cut its holdings in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 22.7% during the first quarter, according to the company in its most recent 13F filing with the Securities a
Halozyme Therapeutics : To Participate In The BMO 2020 Prescriptions For Success Healthcare Conference | MarketScreener
09:09pm, Wednesday, 17'th Jun 2020Halozyme To Participate In The BMO 2020 Prescriptions For Success Healthcare Conference
09:08pm, Wednesday, 17'th Jun 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will be participating in the upcoming BMO 2020 Prescriptions for Success Health
